Effects of Dapagliflozin on Circulating Markers of Phosphate Homeostasis

BACKGROUND AND OBJECTIVES: The sodium glucose cotransporter 2 (SGLT-2) inhibitor dapagliflozin is a novel drug for the treatment of diabetes mellitus. Recent studies suggest that SGLT-2 inhibitors affect phosphate homeostasis, but their effects on phosphate-regulating hormones in patients with diabe...

全面介紹

Na minha lista:
書目詳細資料
發表在:Clin J Am Soc Nephrol
Main Authors: de Jong, Maarten A., Petrykiv, Sergei I., Laverman, Gozewijn D., van Herwaarden, Antonius E., de Zeeuw, Dick, Bakker, Stephan J.L., Heerspink, Hiddo J.L., de Borst, Martin H.
格式: Artigo
語言:Inglês
出版: American Society of Nephrology 2019
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6364523/
https://ncbi.nlm.nih.gov/pubmed/30559106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.04530418
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍